1st Quarter - Report

THE DUBERSTEIN GROUP INC. for PHRMA INC.

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade issues, including the Trans Pacific Partnership Agreement (TPP) - Executive Branch action re this issue.

LobbyistCovered position, as disclosed
DANIEL P MEYER —
DAVID J SCHIAPPA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

21st Century Cures - HR 6, 21st Century Cures Act. Budget resolution and fiscal issues affecting healthcare.

LobbyistCovered position, as disclosed
DANIEL P MEYER —
DAVID J SCHIAPPA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Budget/Appropriations BUD

Budget and the reconciliation process.

LobbyistCovered position, as disclosed
DANIEL P MEYER —
DAVID J SCHIAPPA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Drug pricing issues.

LobbyistCovered position, as disclosed
DANIEL P MEYER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.